Your browser doesn't support javascript.
loading
Short-Term Efficacy and Safety Profile of Generic Bortezomib in the Treatment of Multiple Myeloma / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 137-144, 2021.
Article in Chinese | WPRIM | ID: wpr-880044
ABSTRACT
OBJECTIVE@#To investigate the short-term efficacy and safety of generic bortezomib in the treatment of Chinese patients with multiple myeloma (MM).@*METHODS@#Clinical data of 62 MM patients (median age of 62 years) who had accepted at least 2 cycles of chemotherapy based on generic bortezomib in our center from December 2017 to July 2019 were retrospectively analyzed, including 47 newly diagnosed patients and 15 with disease recurrence or progression.@*RESULTS@#Anemia, renal dysfunction, hypoproteinemia and high level of β @*CONCLUSION@#The disease severity can be rapidly alleviated after generic bortezomib-based chemotherapy, and a favorable short-term efficacy and survival have been observed with a generally acceptable toxicity profile. However, the long-term outcomes will be examined through further follow-up.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Transplantation, Autologous / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Retrospective Studies / Treatment Outcome / Disease-Free Survival / Bortezomib / Multiple Myeloma / Neoplasm Recurrence, Local Type of study: Observational study Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Transplantation, Autologous / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Retrospective Studies / Treatment Outcome / Disease-Free Survival / Bortezomib / Multiple Myeloma / Neoplasm Recurrence, Local Type of study: Observational study Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2021 Type: Article